[ORGANIZATION]
Retatrutide
Featured in 2 tracked stories · first seen
Situations
Eli Lilly retatrutide trials, access & market backdrop
2 clusters · 10 sources · last updated
Latest: Eli Lilly’s Mounjaro sales surge as GLP‑1 weight‑loss drugs spark market and safety debate
Late July 2026 topline data from Phase III TRIUMPH‑2 and TRIUMPH‑3 showed retatrutide induced up to 22.6 % weight loss in severely obese adults with cardiovascular disease, alongside improvements in glycaemic control, li
Also covered in
-
Eli Lilly reports strong phase‑3 results for obesity drug retatrutide
[HEALTH] · 5 sources ·